Early test of new allergy drug shows promise for hay fever relief
NCT ID NCT03570957
Summary
This early-stage study tested a single dose of an experimental drug called MT-2990 in 75 people with Japanese cedar pollen allergies. The main goals were to check the drug's safety and how the body processes it. Researchers also measured if it helped reduce common allergy symptoms like runny nose and itchy eyes when patients were exposed to pollen in a special chamber.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEASONAL ALLERGIC RHINITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.